Omada Health Beats Q3, Raises FY26 Revenue and EBITDA Guidance
OMDA sits 84% above its 52-week low of $10.28.
Summary
Omada Health reported Q3 2026 revenue of $91.3M (+34% YoY), net income of $6.6M and Adjusted EBITDA of $12.4M, then raised full-year revenue and EBITDA guidance.
Key Events · Earnings and Guidance · OMDA
-
Q3 Revenue Up 34% to $91.3M
Revenue rose to $91.3M from $68.0M in Q3 2025, with Total Members up 36% YoY to 1.1 million and average tenure up 10% to about 2 years and 4 months.
-
First Profitable Quarter at Scale
Net income was $6.6M versus a $3.2M net loss a year ago; Adjusted EBITDA reached $12.4M from $2.4M, and GAAP gross margin expanded to 76% from 66%.
-
FY26 Guidance Raised on Both Lines
Revenue outlook lifted to $344M-$346M from $334M-$340M (midpoint ~33% growth), and Adjusted EBITDA to $32M-$34M from $21M-$27M — a midpoint improvement of roughly $27M, about five and a half times 2025.
-
Balance Sheet and Cash Flow
Cash and cash equivalents stood at $243.2M at September 30, 2026, and free cash flow for the first nine months was $2.5M versus -$7.6M a year earlier.
Analysis · OMDA · Industrial Applications And Services
Omada posted its first clearly profitable quarter at scale: revenue of $91.3M (+34% YoY), net income of $6.6M versus a $3.2M loss a year ago, and Adjusted EBITDA of $12.4M against $2.4M. Gross margin jumped to 76% from 66%, showing the software-like economics of the virtual care model are now showing up in the numbers. Management raised full-year revenue guidance to $344M-$346M from $334M-$340M and, more importantly, lifted Adjusted EBITDA guidance to $32M-$34M from $21M-$27M — the midpoint implies roughly $27M of improvement, about five and a half times 2025. With $243.2M of cash and positive free cash flow of $2.5M for the first nine months, the company no longer needs to lean on external capital. The main caveat is that a previously disclosed material weakness in internal controls remains outstanding, and insiders have been steady sellers under 10b5-1 plans — neither undercuts the operating beat, but both are worth knowing.
How filings like this one have moved
In the 30 days to Nov 5, 2026, 43.4% of the 1274 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.16%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, OMDA was trading at $18.95 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $10.28 to $25.54. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.